NCT00129701 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Car J, Sheikh A
Telephone consultations. BMJ. 2003 May 3;326(7396):966-9. doi: 10.1136/bmj.326.7396.966. No abstract available.
Greineder DK, Loane KC, Parks P
Reduction in resource utilization by an asthma outreach program. Arch Pediatr Adolesc Med. 1995 Apr;149(4):415-20. doi: 10.1001/archpedi.1995.02170160069010.
Pal B
Following up outpatients by telephone: pilot study. BMJ. 1998 May 30;316(7145):1647. doi: 10.1136/bmj.316.7145.1647. No abstract available.
Partridge MR
An assessment of the feasibility of telephone and email consultation in a chest clinic. Patient Educ Couns. 2004 Jul;54(1):11-3. doi: 10.1016/S0738-3991(03)00166-6.
Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price D, Sheikh A
Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BMJ. 2003 Mar 1;326(7387):477-9. doi: 10.1136/bmj.326.7387.477.
Roberts NJ, Partridge MR
Telephone consultations in secondary care. Respir Med. 2007 Aug;101(8):1665-9. doi: 10.1016/j.rmed.2007.03.003. Epub 2007 Apr 19.

Proposal to Study Whether we Can Reduce Hospital Attendance by Those With Respiratory Conditions Without Compromising Care by the Use of Telephone Consultation

Details for clinical trial NCT00129701

Clinical trial NCT00129701 - References